Mar 08, 2026 by Will Chu, CRTonline.org
The use of a sirolimus-eluting balloon (SEB) with provisional stenting results in one-year outcomes that are comparable to systematic drug-eluting stent (DES) implantation for the treatment of de novo coronary lesions, according to findings presented by Christian Spaulding, MD, PhD.